Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 09 - 28 symbols : SNYNF save search
Press Release: Dupixent® (dupilumab) approved by FDA as the first and only treatment indicated for prurigo nodularis
Published: 2022-09-28 (Crawled : 23:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.22%
H: 0.33%
C: 0.33%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.08%
H: 0.25%
C: -1.85%
dupixent treatment fda approved
Dupixent® (dupilumab) Approved by FDA as the First and Only Treatment Indicated for Prurigo Nodularis
Published: 2022-09-28 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.22%
H: 0.33%
C: 0.33%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.08%
H: 0.25%
C: -1.85%
dupixent treatment fda approved
Global Glaucoma Treatment Market to Grow at 5.2% Annually Through 2027
Published: 2022-09-28 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.22%
H: 0.33%
C: 0.33%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.87%
H: 0.0%
C: 0.0%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.05%
H: 0.47%
C: -0.56%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.17%
H: 1.1%
C: 0.16%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.05%
H: 0.41%
C: -1.17%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.08%
H: 0.25%
C: -1.85%
AERI | $15.25 0.0%
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: -0.13%
treatment glaucoma global market
Top 10 Best Locations for Life Science Jobs in the World
Published: 2022-09-28 (Crawled : 15:20) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
life
Immune Health Supplements Market is Expected to See a growth of 10.2% CAGR between 2022 and 2032 | Future Market Insights, Inc.
Published: 2022-09-28 (Crawled : 15:20) - prnewswire.com
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.26%
H: 1.22%
C: 0.66%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
health expected growth market
Ironshore Announces Executive Appointments and Strengthening of the Global Business Management Team
Published: 2022-09-28 (Crawled : 13:20) - biospace.com/
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: -0.26%
H: 1.22%
C: 0.66%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
management global
Global Digital Diabetes Management Market to Reach $21.9 Billion by 2030 at an 8% CAGR
Published: 2022-09-28 (Crawled : 11:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
PODD | $166.255 0.93% 0.92% 840K
|
Health Technology
|
| O: 1.38%
H: 1.27%
C: 1.01%
management global diabetes market
USD 28.28 Bn growth expected in Vaccines Market -- Driven by increased funding for vaccine development and new vaccine launches
Published: 2022-09-28 (Crawled : 09:00) - prnewswire.com
CMXHF | $172.54 -19.21% 50
|
n/a
|
| O: -0.61%
H: 0.0%
C: 0.0%
MTLHY | $29.93 -11.69% 1.1K
|
n/a
|
| O: 1.63%
H: 0.0%
C: -0.48%
CSLLY | $86.918 3.3% 60K
|
n/a
|
| O: -0.43%
H: 1.81%
C: 1.44%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.05%
H: 4.0%
C: 4.0%
AZNCF | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.35%
H: 0.0%
C: -0.68%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -1.91%
H: 2.64%
C: 1.94%
GSK | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 1.12%
H: 2.14%
C: 1.66%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.04%
H: 3.14%
C: 2.68%
vaccine expected funding growth market
Press Release: Availability of the Q3 2022 Memorandum for modelling purposes
Published: 2022-09-28 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.